269 results
Page 4 of 14
8-K
EX-99.1
kyae4018q9wn1e0t
24 Feb 22
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:14pm
8-K
EX-99.1
k9yokp
15 Feb 22
Vaxart Appoints Edward Berg as Senior Vice President and General Counsel
4:02pm
8-K
EX-99.1
7rbmx c2x
1 Dec 21
Vaxart Announces Acquisition of Second GMP Manufacturing Facility
4:00pm
8-K
EX-99.1
8xla bxgw43g39ujw
4 Nov 21
Vaxart Provides Business Update and Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-10.1
6flnqcex6tk4lyy2m br
21 Sep 21
Entry into a Material Definitive Agreement
4:18pm
424B5
zca he8mraskpw
15 Sep 21
Prospectus supplement for primary offering
9:47pm
8-K
EX-1.1
hjxsivl38sc
15 Sep 21
Entry into a Material Definitive Agreement
9:47pm
8-K
EX-99.1
zhv009p
23 Aug 21
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
4:23pm
8-K
EX-99.1
p82gavmi
5 Aug 21
Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results
4:08pm
8-K
ubwbn7
2 Aug 21
Results of Operations and Financial Condition
4:11pm